Covered recipient · General Payments record
JOHN JOSEPH GORMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,311.74
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $307.66 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $220.00 | 13 |
| PFIZER INC. | $38.15 | 2 |
| Novo Nordisk AS | $33.08 | 2 |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.86 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822962 | CMS |
| ABBVIE INC. | $3.46 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822964 | CMS |
| ABBVIE INC. | $13.29 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822966 | CMS |
| ABBVIE INC. | $30.69 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822968 | CMS |
| ABBVIE INC. | $11.58 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822970 | CMS |
| ABBVIE INC. | $18.42 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822972 | CMS |
| ABBVIE INC. | $1.71 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822974 | CMS |
| ABBVIE INC. | $22.62 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822976 | CMS |
| ABBVIE INC. | $20.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822978 | CMS |
| ABBVIE INC. | $14.10 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822980 | CMS |
| ABBVIE INC. | $18.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822982 | CMS |
| ABBVIE INC. | $26.21 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822984 | CMS |
| ABBVIE INC. | $17.06 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103822986 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101678802 | CMS |
| Novo Nordisk Inc | $16.22 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096716407 | CMS |
| Novo Nordisk Inc | $16.86 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097199696 | CMS |
| PFIZER INC. | $15.13 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131263498 | CMS |
| PFIZER INC. | $23.02 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131646133 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.